skip to Main Content
Pakistani American Pharmacist Association
Step 1 of 3
ExcellentGoodFairPoor
Overall program
Program organization and format
Relevance to personal needs
Overall knowledge of topics presented
Overall quality of speakers’ presentation
Dr. Vincent Tao
Dr. Ali Jalani
Dr. Ghania Naeem
Dr. Fawad Piracha
Dr. Elena Mercedes-Rico
Dr. Samad Tirmizi
Value of discussion time
Course materials distributed
Physical facilities
Refreshments
Scheduled date and time

Using the same scale as above, please indicate how well the following program learning objectives were met:

ExcellentGoodFairPoor
Review the pathophysiology of tumor lysis syndrome (TLS)
Identify the risk factors and types of pediatric cancers that are at high risk for TLS
Discuss the management of TLS using both non-pharmacological and pharmacological interventions
ExcellentGoodFairPoor
Explain what deprescribing is and its relevance in pharmacy
Review patients at high risk for inappropriate prescribing and medications
Barriers and Facilitators to deprescribing
Explore tools and strategies for deprescribing
Role of pharmacists in deprescribing
ExcellentGoodFairPoor
Discuss the background information and previous guideline recommendations for heart failure (HF).
Evaluate the efficacy and tolerability data of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in HF management from published clinical trials
Evaluate the 2022 updated HF classifications based on left ventricular ejection fraction (LVEF) and the corresponding treatment strategies.
Summarize the key similarities and differences between the previous guideline recommendations and the 2022 updated guideline recommendations.
Apply evidence-based literature findings to make recommendations for patient care
ExcellentGoodFairPoor
Provide an overview of indications for immunoglobulin therapy
Discuss the manufacturing and purification of immunoglobulin
Compare intravenous versus subcutaneous administration
Explain the dosing of immunoglobulin
Discuss the relationship between dose, level, and efficacy
Explain immunoglobulin therapy for immunomodulation
ExcellentGoodFairPoor
Explain trends in asthma prevalence, morbidity and mortality
Discuss the strategy for asthma treatment
Review the 2022 Updates from the Global Initiative for Asthma (GINA)
Describe Role of Pharmacist in Asthma Education and Management
ExcellentGoodFairPoor
Recognize the paradigm of colorectal cancer burden reduction
Explain the mt-sDNA Test and its clinical Performance
Analyze the clinical application of the mt-sDNA test
Evaluate patient cases in relation to CRC screening options
Very lowLowAverageHighHigest
How would you rate your knowledge level of the subject matter discussed prior to the presentation(s)
Very LowLowAverageHighHigest
How would you rate your knowledge level of the subject matter discussed following the presentation(s)

Thank Your For Your Input

Back To Top